Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 269

1.

Severe vitamin D deficiency is associated with emphysema progression in male patients with COPD.

Kim C, Ko Y, Jung JY, Lee JS, Rhee CK, Lee JH, Lee JH, Moon JY, Lim SY, Yoo KH, Seo JB, Oh YM, Lee SD, Park YB.

Respir Med. 2020 Jan 30;163:105890. doi: 10.1016/j.rmed.2020.105890. [Epub ahead of print]

PMID:
32056836
2.

Association between peripheral blood/bronchoalveolar lavage eosinophilia and significant oxygen requirements in patients with acute eosinophilic pneumonia.

Choi JY, Lim JU, Jeong HJ, Lee JE, Rhee CK.

BMC Pulm Med. 2020 Jan 28;20(1):22. doi: 10.1186/s12890-020-1056-7.

3.

KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea.

Lee H, Choi H, Sim YS, Park S, Kim WJ, Yoo KH, Lee SJ, Kim TH, Yang B, Jeong I, Um SJ, Kim DK, Lee JH, Kwon BS, Cho YJ, Park HY, Lee CH, Rhee CK, Lee SH, Na JO, Jang AS, Jung JY, Ra SW, Lee JH, Kim SH, Kim C, Kim Y, Lee CY, Kim HK, Lee JS, Lee SW, Oh YM; KMBARC.

BMJ Open. 2020 Jan 19;10(1):e034090. doi: 10.1136/bmjopen-2019-034090.

4.

Effect of Inhaled Corticosteroids on Exacerbation of Asthma-COPD Overlap According to Different Diagnostic Criteria.

Jo YS, Hwang YI, Yoo KH, Kim TH, Lee MG, Lee SH, Shin KC, In KH, Yoon HK, Rhee CK; Korean Asthma Research Group & KOCOSS cohort.

J Allergy Clin Immunol Pract. 2020 Jan 15. pii: S2213-2198(20)30042-8. doi: 10.1016/j.jaip.2020.01.004. [Epub ahead of print]

PMID:
31953230
5.

CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition.

Choi JY, Yoon HK, Shin KC, Park SY, Lee CY, Ra SW, Jung KS, Yoo KH, Lee CH, Rhee CK.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 30;14:3043-3052. doi: 10.2147/COPD.S228307. eCollection 2019.

6.

Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients.

Lim JU, Kim EK, Lim SY, Lee JH, Lee JS, Lee SD, Oh YM, Rhee CK; KOLD Study Group.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 30;14:3035-3042. doi: 10.2147/COPD.S227377. eCollection 2019.

7.

Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations.

Yoon S, Kim TE, Kim TH, Na JO, Shin KC, Rhee CK, Jung SS, Choe KH, Yoo KH.

J Korean Med Sci. 2020 Jan 13;35:e10. doi: 10.3346/jkms.2020.35.e10.

8.

Clinical Characteristics of Chronic Cough in Korea.

An TJ, Kim JW, Choi EY, Jang SH, Lee HY, Kang HS, Koo HK, Lee JM, Kim SK, Shin JW, Park SY, Rhee CK, Moon JY, Kim YH, Lee H, Kim YH, Kim JH, Lee SH, Kim DK, Yoo KH, Kim DG, Jung KS, Kim HJ, Yoon HK; Cough Study Group of the Korean Academy of Tuberculosis and Respiratory Diseases.

Tuberc Respir Dis (Seoul). 2020 Jan;83(1):31-41. doi: 10.4046/trd.2019.0018.

9.

HL301 versus Umckamin in the treatment of acute bronchitis: a phase III, randomized, controlled, double-blind, multicenter study.

Kim WY, Park MJ, Rhee CK, Lee SY, Kim DJ, Kim DG, Choi CM, Kim DK, Kim YH, Yoon HJ, Kim JY.

Curr Med Res Opin. 2020 Jan 3:1-6. doi: 10.1080/03007995.2019.1706044. [Epub ahead of print]

PMID:
31855086
10.

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs.

Choi HS, Rhee CK, Park YB, Yoo KH, Lim SY.

Int J Chron Obstruct Pulmon Dis. 2019 Dec 10;14:2873-2883. doi: 10.2147/COPD.S228497. eCollection 2019.

11.

Enhanced mitochondrial membrane potential and ATP synthesis by photobiomodulation increases viability of the auditory cell line after gentamicin-induced intrinsic apoptosis.

Chang SY, Lee MY, Chung PS, Kim S, Choi B, Suh MW, Rhee CK, Jung JY.

Sci Rep. 2019 Dec 17;9(1):19248. doi: 10.1038/s41598-019-55711-9.

12.

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.

Lee JK, Rhee CK, Kim K, Ra SW, Lee JH, Jung KS, Yoo KH, Kim YI, Kim DK.

Int J Chron Obstruct Pulmon Dis. 2019 Nov 27;14:2639-2647. doi: 10.2147/COPD.S216326. eCollection 2019.

13.

Nanotechnology as a savior in asthma management.

Rhee CK.

Ann Transl Med. 2019 Oct;7(20):517. doi: 10.21037/atm.2019.09.98. No abstract available.

14.

Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.

Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, Busby J, Jackson DJ, Pfeffer PE, Rhee CK, Cho YS, Canonica GW, Heffler E, Gibson PG, Hew M, Peters M, Harvey ES, Alacqua M, Zangrilli J, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Hosseini N, Murray RB, Price DB.

Chest. 2019 Nov 27. pii: S0012-3692(19)34295-3. doi: 10.1016/j.chest.2019.10.053. [Epub ahead of print]

15.

Burden and clinical characteristics of high grade tuberculosis destroyed lung: a nationwide study.

Han D, Lee HY, Kim K, Kim T, Oh YM, Rhee CK.

J Thorac Dis. 2019 Oct;11(10):4224-4233. doi: 10.21037/jtd.2019.09.63.

16.

The Difficulty Of Improving Quality Of Life In COPD Patients With Depression And Associated Factors.

Lim JU, Park CK, Kim TH, Jang AS, Park YB, Rhee CK, Jung KS, Yoo KH, Lee WY, Yoon HK.

Int J Chron Obstruct Pulmon Dis. 2019 Oct 9;14:2331-2341. doi: 10.2147/COPD.S216746. eCollection 2019.

17.

Mortality of patients with chronic obstructive pulmonary disease: a nationwide populationbased cohort study.

Park SC, Kim DW, Park EC, Shin CS, Rhee CK, Kang YA, Kim YS.

Korean J Intern Med. 2019 Nov;34(6):1272-1278. doi: 10.3904/kjim.2017.428. Epub 2019 Oct 16.

18.

Pravastatin alleviates allergic airway inflammation in obesity-related asthma mouse model.

Lee HY, Lee EG, Hur J, Rhee CK, Kim YK, Lee SY, Kang JY.

Exp Lung Res. 2019 Nov - Dec;45(9-10):275-287. doi: 10.1080/01902148.2019.1675807. Epub 2019 Oct 12.

PMID:
31608695
19.

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia.

Kim MH, Rhee CK, Shim JS, Park SY, Yoo KH, Kim BY, Bae HW, Sim YS, Chang JH, Cho YJ, Lee JH.

Allergy Asthma Immunol Res. 2019 Nov;11(6):795-805. doi: 10.4168/aair.2019.11.6.795.

20.

Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study.

Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 25;14:1595-1601. doi: 10.2147/COPD.S208245. eCollection 2019.

21.

Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study.

Park HY, Kang D, Lee H, Shin SH, Kang M, Kong S, Rhee CK, Cho J, Yoo KH.

Respirology. 2019 Aug 19. doi: 10.1111/resp.13678. [Epub ahead of print]

PMID:
31426128
22.

Clinical characteristics and economic burden of tuberculous-destroyed lung in Korea: a National Health Insurance Service-National Sample Cohort-based study.

Lee HY, Han DJ, Kim KJ, Kim TH, Oh YM, Rhee CK.

J Thorac Dis. 2019 Jun;11(6):2324-2331. doi: 10.21037/jtd.2019.06.14.

23.

Photoluminescence imaging of europium (III)-doped γ-Al2 O3 nanofiber structures.

Park SJ, Rhee CK, Sohn Y.

Luminescence. 2019 Dec;34(8):838-845. doi: 10.1002/bio.3680. Epub 2019 Jul 16.

PMID:
31313470
24.

Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology.

Rhee CK, Chau NQ, Yunus F, Matsunaga K, Perng DW; on behalf the COPD Assembly of the APSR.

Respirology. 2019 Oct;24(10):1018-1025. doi: 10.1111/resp.13633. Epub 2019 Jul 5.

25.

Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.

Krishnan JA, Nibber A, Chisholm A, Price D, Bateman ED, Bjermer L, van Boven JFM, Brusselle G, Costello RW, Dandurand RJ, Diamant Z, Van Ganse E, Gouder C, van Kampen SC, Kaplan A, Kocks J, Miravitlles M, Niimi A, Pizzichini E, Rhee CK, Soriano JB, Vogelmeier C, Román-Rodriguez M, Carter V, D'Urzo AD, Roche N.

Ann Am Thorac Soc. 2019 Sep;16(9):1143-1150. doi: 10.1513/AnnalsATS.201809-607OC.

PMID:
31162945
26.

Changes in critically ill cancer patients' short-term outcome over the last decades: results of systematic review with meta-analysis on individual data.

Darmon M, Bourmaud A, Georges Q, Soares M, Jeon K, Oeyen S, Rhee CK, Gruber P, Ostermann M, Hill QA, Depuydt P, Ferra C, Toffart AC, Schellongowski P, Müller A, Lemiale V, Mokart D, Azoulay E.

Intensive Care Med. 2019 Jul;45(7):977-987. doi: 10.1007/s00134-019-05653-7. Epub 2019 May 29. Review.

PMID:
31143998
27.

Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.

Lim JU, Yeo CD, Rhee CK, Kang HS, Park CK, Kim JS, Kim JW, Kim SJ, Yoon HK, Lee SH.

Int J Chron Obstruct Pulmon Dis. 2019 May 1;14:929-938. doi: 10.2147/COPD.S190244. eCollection 2019.

28.
30.

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis.

Lee J, Jung HM, Kim SK, Yoo KH, Jung KS, Lee SH, Rhee CK.

Sci Rep. 2019 Apr 30;9(1):6679. doi: 10.1038/s41598-019-43167-w.

31.

HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study.

Yoon SW, Park MJ, Rhee CK, Park JH, Lee SY, Kim DJ, Kim DG, Kim JY.

Korean J Intern Med. 2020 Jan;35(1):133-141. doi: 10.3904/kjim.2018.181. Epub 2019 Apr 9.

32.

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation.

Kim HC, Kim TH, Rhee CK, Han M, Oh YM.

Ther Clin Risk Manag. 2019 Mar 5;15:377-387. doi: 10.2147/TCRM.S194324. eCollection 2019.

33.

The Economic Effect of Early Management in Patients with Early Chronic Obstructive Pulmonary Disease: Results from a Population-Based Nationwide Survey.

Lee YS, Min KH, Rhee CK, Kim YH, Lim SY, Um SJ, Lee CH, Jung KS, Yoo KH.

Lung. 2019 Jun;197(3):303-313. doi: 10.1007/s00408-019-00208-5. Epub 2019 Mar 11.

PMID:
30859313
34.

Comparison of clinical efficacy between ultra-LABAs and ultra-LAMAs in COPD: a systemic review with meta-analysis of randomized controlled trials.

Cho EY, Kim SY, Kim MJ, Kim S, Park DA, Yoo KH, Park YB, Hwang YI, Rhee CK, Jung JY, Lee H, Park HY.

J Thorac Dis. 2018 Dec;10(12):6522-6530. doi: 10.21037/jtd.2018.11.50.

35.

Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives.

Rhee CK, Yoshisue H, Lad R.

Adv Ther. 2019 Mar;36(3):495-519. doi: 10.1007/s12325-019-0893-3. Epub 2019 Feb 11. Review.

36.

Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011-2018.

Kim TO, Shin HJ, Kim YI, Rhee CK, Lee WY, Lim SY, Ra SW, Jung KS, Yoo KH, Park SJ, Lim SC.

Chonnam Med J. 2019 Jan;55(1):47-53. doi: 10.4068/cmj.2019.55.1.47. Epub 2019 Jan 25.

37.

Male current smokers have low awareness and optimistic bias about COPD: field survey results about COPD in Korea.

Hwang YI, Park YB, Yoon HK, Kim TH, Yoo KH, Rhee CK, Park JH, Jang SH, Park S, Kim JH, Park J, Jung KS.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 21;14:271-277. doi: 10.2147/COPD.S189859. eCollection 2019.

38.

Development and validation of the COugh Assessment Test (COAT).

Koo HK, Jeong I, Kim JH, Kim SK, Shin JW, Park SY, Rhee CK, Choi EY, Moon JY, Kim YH, Lee H, Kang HS, Min KH, Kim JW, Kim JH, Lee SH, Yoo KH, Kim DK, Yoon HK, Kim DG, Kim HJ, Jung KS, Jang SH; Cough Study Group of the Korean Academy of Tuberculosis and Respiratory Diseases.

Respirology. 2019 Jun;24(6):551-557. doi: 10.1111/resp.13462. Epub 2019 Jan 25.

PMID:
30681246
39.

Effect of nintedanib on airway inflammation in a mouse model of acute asthma.

Lee J, Rhee CK, Lee JH, Yoon HJ, Kim IK, Hur J, Kang JY, Yoon HK, Lee SY, Kim YK.

J Asthma. 2020 Jan;57(1):11-20. doi: 10.1080/02770903.2018.1544641. Epub 2019 Jan 11.

PMID:
30634874
40.

Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation.

Kim TH, Rhee CK, Oh YM.

Tuberc Respir Dis (Seoul). 2019 Jan;82(1):35-41. doi: 10.4046/trd.2018.0050.

41.

Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data.

Georges Q, Azoulay E, Mokart D, Soares M, Jeon K, Oeyen S, Rhee CK, Gruber P, Ostermann M, Hill QA, Depuydt P, Ferra C, Toffart AC, Schellongowski P, Müller A, Lemiale V, Tinquaut F, Bourmaud A, Darmon M.

Crit Care. 2018 Dec 4;22(1):326. doi: 10.1186/s13054-018-2076-z.

42.

Blood eosinophil count as a prognostic biomarker in COPD.

Oh YM, Lee KS, Hong Y, Hwang SC, Kim JY, Kim DK, Yoo KH, Lee JH, Kim TH, Lim SY, Rhee CK, Yoon HK, Lee SY, Park YB, Jung JH, Kim WJ, Lee SD, Park JH.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 31;13:3589-3596. doi: 10.2147/COPD.S179734. eCollection 2018.

43.

Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study.

Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, Rhee CK, Park SJ, Shim JJ.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 18;13:3411-3417. doi: 10.2147/COPD.S174545. eCollection 2018.

44.

Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD.

Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, Rhee CK, Park SJ, Shim JJ.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 18;13:3381-3387. doi: 10.2147/COPD.S177371. eCollection 2018.

45.

Nationwide use of inhaled corticosteroids by South Korean asthma patients: an examination of the Health Insurance Review and Service database.

Choi JY, Yoon HK, Lee JH, Yoo KH, Kim BY, Bae HW, Kim YK, Rhee CK.

J Thorac Dis. 2018 Sep;10(9):5405-5413. doi: 10.21037/jtd.2018.08.110.

46.

Elevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation.

Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, Rhee CK, Park SJ, Shim JJ.

J Thorac Dis. 2018 Sep;10(9):5246-5253. doi: 10.21037/jtd.2018.08.29.

47.

Which GOLD B patients progress to GOLD D with the new classification?

Choi HS, Na JO, Lee JD, Shin KC, Rhee CK, Hwang YI, Lim SY, Yoo KH, Jung KS, Park YB.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 12;13:3233-3241. doi: 10.2147/COPD.S177944. eCollection 2018.

48.

Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea.

Kim C, Kim Y, Yang DW, Rhee CK, Kim SK, Hwang YI, Park YB, Lee YM, Jin S, Park J, Hahm CR, Park CH, Park SY, Jung CK, Kim YI, Lee SH, Yoon HK, Lee JH, Lim SY, Yoo KH.

Tuberc Respir Dis (Seoul). 2019 Jan;82(1):27-34. doi: 10.4046/trd.2018.0035. Epub 2018 Sep 28.

49.

Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation.

Rhee CK, van Boven JFM, Yau Ming SW, Park HY, Kim DK, Park HS, Ling JZJ, Yoo KH, Price DB.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):934-942. doi: 10.1016/j.jaip.2018.09.027. Epub 2018 Oct 5.

PMID:
30292924
50.

Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.

Park HJ, Byun MK, Rhee CK, Kim K, Kim HJ, Yoo KH.

Respir Res. 2018 Sep 24;19(1):185. doi: 10.1186/s12931-018-0896-7.

Supplemental Content

Support Center